Corrigendum to “pH-Sensitive tumor-targeted hyperbranched system based on glycogen nanoparticles for liver cancer therapy”
Yuning Han(Hangzhou Medical College), Jinghua Chen(Chinese Academy of Medical Sciences & Peking Union Medical College), Yang Yang(Jiangnan University), Juan Zhou(Jiangnan University), Bin Hu(Jiangnan University), Li Zhang(Fourth Hospital of Changsha), Mingyu Wang(Hebei Agricultural University)
Cited by 1
Related Papers
A Perivascular Origin for Mesenchymal Stem Cells in Multiple Human Organs
|Cell stem cell|2008|4k
Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)
|The Journal of Experimental Medicine|2000|582
Five-Year Outcomes With Pembrolizumab Versus Chemotherapy as First-Line Therapy in Patients With Non–Small-Cell Lung Cancer and Programmed Death Ligand-1 Tumor Proportion Score ≥ 1% in the KEYNOTE-042 Study
|Journal of Clinical Oncology|2022|334
In situ formed collagen-hyaluronic acid hydrogel as biomimetic dressing for promoting spontaneous wound healing
|Materials Science and Engineering C|2019|280